Gastroenteritis treatment

Reading File
Finding Sources
Searching PubMed

"gastroenteritis" AND "treatment"

Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
I have comprehensive information from two authoritative emergency medicine textbooks. Let me now compile a thorough answer.

Gastroenteritis Treatment

Acute gastroenteritis is usually self-limited and most cases require only supportive care. The core goals are: (1) prevent or correct dehydration, (2) replace ongoing losses, (3) meet nutritional needs.

1. Oral Rehydration Therapy (ORT) — First-Line

ORT is the cornerstone of treatment, recommended by the WHO, AAP, and ESPGHAN for mild-to-moderate dehydration. Its mechanism relies on sodium-glucose cotransport at the intestinal brush border, which drives passive water absorption and remains largely intact even during severe diarrhea.
Preferred solutions:
SolutionOsmolarityNa (mmol/L)Notes
WHO reduced-osmolarity ORS (2002)245 mOsm/L75First choice
Pedialyte250 mOsm/L45Common in North America
Standard WHO ORS331 mOsm/L90Older formulation
  • Reduced-osmolarity ORS is associated with less vomiting, lower stool volume, and fewer IV top-ups compared to the standard formulation.
  • Sports drinks (Gatorade) and diluted chicken broth are acceptable in adults. Dilute apple juice followed by preferred fluids is a reasonable alternative in children with mild gastroenteritis and minimal dehydration (fewer treatment failures vs. electrolyte maintenance solutions in high-income countries).
  • Avoid plain water, undiluted juice, tea, or sodas — insufficient sodium, excessive sugar.
IV rehydration is reserved for severe dehydration, hemodynamic compromise, altered mental status, or persistent vomiting precluding oral intake. A Cochrane review found no difference in rehydration success between ORT and IV therapy; ORT is associated with shorter hospital stays.

2. Antiemetics

Antiemetics facilitate ORT by reducing vomiting.
  • Ondansetron (5-HT₃ antagonist): 0.15 mg/kg IV or PO, up to 8 mg — safe and cost-effective; preferred agent.
  • Metoclopramide or promethazine may be used as alternatives in adults.

3. Antimotility Agents

  • Loperamide (Imodium): Initial 4 mg PO, then 2 mg after each loose stool, max 16 mg/day for 48 hours. Reduces stool frequency and prevents dehydration.
    • Contraindicated in children < 18 years (risk of ileus, lethargy, death in infants < 3 years).
    • Caution with suspected bacterial dysentery: if used, must be co-administered with antibiotics (antimotility agents increase toxin contact time with mucosa).
  • Diphenoxylate/atropine (Lomotil): similar action; similar contraindications.
  • Absolutely avoid in bloody diarrhea from STEC (E. coli O157:H7) or Shiga toxin-producing organisms — increases risk of HUS/TTP.

4. Diet / Nutrition

  • Continue feeding throughout illness — fasting worsens bowel absorptive capacity.
  • Continue breast-feeding in infants.
  • Resume a normal age-appropriate diet as soon as tolerated (BRAT diet is no longer routinely recommended).
  • Zinc 20 mg/day PO in moderately-to-severely malnourished children > 6 months reduces diarrhea duration by ~1 day (side effects: vomiting, metallic taste).

5. Antibiotics

Not indicated for the vast majority of acute gastroenteritis cases. Consider antibiotics in:
IndicationPreferred Regimen
Empiric (toxic, febrile, dysentery)Azithromycin 500 mg/day PO × 3 days OR ciprofloxacin 500 mg bid × 3–5 days
CampylobacterAzithromycin 500 mg/day × 3 days
ShigellaAzithromycin or fluoroquinolone
Severe traveler's diarrheaAzithromycin or rifaximin
C. difficileVancomycin 125 mg PO q8h × 10 days (or fidaxomicin)
GiardiaMetronidazole + rehydration
Vibrio choleraeTetracycline or doxycycline
Important caveats:
  • Antibiotics prolong Salmonella shedding — avoid unless the patient is immunocompromised, has prosthetic hardware, or is at risk for dissemination.
  • Never use antibiotics for STEC/E. coli O157:H7 — increases HUS incidence.

6. Special Populations

  • Children: ORT is first-line; avoid loperamide; ondansetron safe.
  • Immunocompromised (HIV, CD4 < 200/mm³): Broaden differential to CMV, Cryptosporidium, Cyclospora, Isospora, MAC, Giardia; more aggressive workup warranted.
  • Elderly: Higher morbidity/mortality; lower threshold for admission and electrolyte monitoring.
  • C. difficile risk (recent antibiotics, hospitalization, PPI use): Stool GDH/toxin testing; treat with vancomycin or fidaxomicin.

7. Disposition

  • Outpatient (majority): written instructions for fluid intake, diet, return precautions.
  • Admit if: toxic appearance, severe/persistent symptoms, inability to tolerate oral liquids, significant electrolyte abnormalities, severe dehydration, extremes of age, or immunocompromised state.

Sources: Tintinalli's Emergency Medicine (9th ed.); Rosen's Emergency Medicine (10th ed.)
Recent evidence note: Three 2025 meta-analyses (PMIDs 40535538, 40381158, 40739406) support the use of probiotics (especially Saccharomyces boulardii CNCM I-745 and Bacillus clausii) in pediatric acute gastroenteritis to reduce duration and severity — consistent with growing but still evolving evidence. No major contradictions to current standard-of-care guidelines were identified.
This is a shared conversation. Sign in to Orris to start your own chat.